
Biomednewsbreaks - Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Advances TNX-1500 To Address Organ Transplant ...
(MENAFN- Investor Brand Network) Tonix Pharmaceuticals (NASDAQ: TNXP) is working to improve organ transplant success rates with TNX-1500, a third-generation CD40L blocker designed to modulate the immune system while reducing the risk of rejection. …